Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases.
Saved in:
| Title: | Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases. |
|---|---|
| Authors: | Protić-Rosić, Isidora1,2 (AUTHOR), Sehgal, Al Nasar Ahmed1,2 (AUTHOR), Wrighton, Sebastian1,3 (AUTHOR), Heller, Birgit3,4 (AUTHOR), Pickl, Winfried F.1,4 (AUTHOR) winfried.pickl@meduniwien.ac.at |
| Source: | Cells (2073-4409). May2025, Vol. 14 Issue 10, p753. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
